Behavioral correlations of dopamine receptor activation

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Neurology

• Publication date

  1983-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1212/WNL.33.11.1489PMID 6605497
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity.

  1982cited by this paper
• Pergolide‐induced circling in rats with 6‐hydroxydopamine lesions in the nigrostriatal pathway

  1982cited by this paper
• PHARMACOLOGICAL EVIDENCE FOR THE SUBCLASSIFICATION OF CENTRAL DOPAMINE RECEPTORS IN THE RAT

  1982cited by this paper
• Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by partial ergoline.

  1981cited by this paper
• Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor

  1981cited by this paper
• Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

  1981cited by this paper
• Brain dopamine receptors.

  1980cited by this paper
• Interaction of pergolide with central dopaminergic receptors.

  1980cited by this paper
• The role of D-1 and D-2 receptors

  1980cited by this paper
• Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists.

  1980cited by this paper
• DOPAMINERGIC ERGOT DERIVATIVES: SELECTIVE AGONISTS OF A NEW CLASS OF DOPAMINE RECEPTORS?

  1979cited by this paper
• Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: dependence upon dopamine uptake inhibition.

  1979cited by this paper
• Multiple receptors for dopamine

  1979cited by this paper
• ACTIONS OF ERGOT DERIVATIVES AT DOPAMINE SYNAPSES

  1979cited by this paper
• DOPAMINERGIC ERGOTS: DRUGS WHICH DISCRIMINATE BETWEEN THE MULTIPLE CLASSES OF DOPAMINE RECEPTORS

  1979cited by this paper
• Circling induced by dopamine uptake inhibitors *

  1978cited by this paper
• The central effects of a novel dopamine agonist.

  1978cited by this paper

• Locomotor activity depends on β-arrestin recruitment by the dopamine D1 receptor in the striatal D1-D3 receptor heteromer.

  2025cites this paper
• Virtual Compound Screening for Discovery of Dopamine D1 Receptor Biased Allosteric Modulators

  2025cites this paper
• Tips and tricks in tremor treatment

  2024cites this paper
• A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in nucleus accumbens shell in rats.

  2021cites this paper
• Heteromer formation between cannabinoid type 1 and dopamine type 2 receptors is altered by combination cannabinoid and antipsychotic treatments

  2020cites this paper
• The effects of early life stress on motivated behaviors: A role for gonadal hormones.

  2020cites this paper
• Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics.

  2019cites this paper
• Synthesis and Pharmacological Evaluation of Noncatechol G Protein Biased and Unbiased Dopamine D1 Receptor Agonists.

  2019cites this paper
• Evaluation of efavirenz on neurochemical and oxidative stress markers and addictive-like behaviours in rats

  2018cites this paper
• Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor

  2018cites this paper
• Unilateral Botulinum Neurotoxin-A Injection into the Striatum of C57BL/6 Mice Leads to a Different Motor Behavior Compared with Rats

  2018cites this paper
• ALLOSTERIC INTERACTIONS WITHIN CANNABINOID RECEPTOR 1 (CB1) AND DOPAMINE RECEPTOR 2 LONG (D2L) HETEROMERS

  2017cites this paper
• Synthesis and Evaluation of Tetrahydroprotoberberines as Dopamine Receptor Ligands

  2017cites this paper
• Intravenous Delivery of a D1-D2 Interfering Peptide with Antidepressant-like Effects

  2017cites this paper
• Abnormal Activities in Cortico-Basal Ganglia Circuits in Movement Disorders

  2016cites this paper
• Dopamine D1 Receptor Agonists

  2012cites this paper
• Towards a Novel Treatment of Huntington´s Disease

  2011cites this paper
• Synthesis and pharmacological evaluation of 5,6,7,8‐tetrahydro‐6‐[propyl[2‐(2‐thienyl)ethyl]amino]‐1,2‐naphthalenediol: A novel non‐selective dopamine‐receptor agonist

  2010cites this paper
• Synchronous Activity in Basal Ganglia Circuits

  2010cites this paper
• Basal Ganglia Network Synchronization in Animal Models of Parkinson’s Disease

  2009cites this paper
• Characterization of dopamine D 1 receptor agonists in vivo-Implications for the treatment of schizophrenia and Parkinson ’ s disease

  2008cites this paper
• Characterization of dopamine D1 receptor agonists in vivo- Implications for the treatment of schizophrenia and Parkinson s disease

  2008cites this paper
• Twenty years of dopamine research: individual differences in the response of accumbal dopamine to environmental and pharmacological challenges.

  2008cites this paper
• Interactions of the Striatal Gene Rhes with the Dopaminergic System in Rodents

  2007cites this paper
• Genetic Influences on Smoking Behavior and Nicotine Dependence: a Review

  2007cites this paper
• Rapidly induced dopaminergic supersensitivity: D1/D2 receptor participation and its prevention by an MAO-inhibitor.

  2006cites this paper
• Involvement of dopamine receptor subtypes in mouse thermoregulation

  2005cites this paper
• Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to MPTP-treated common marmosets

  2005cites this paper
• Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats.

  2005cites this paper
• In vivo receptor binding, neurochemical and functional studies with the dopamine D-1 receptor antagonist SCH 23390

  2005cites this paper
• Motor activity following the administration of selective D-1 and D-2 dopaminergic drugs to normal common marmosets

  2005cites this paper
• Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists

  2005cites this paper
• Selective D-1 dopamine receptor agonist treatment of parkinson's disease

  2005cites this paper
• Differential involvement of dopamine D-1 and D-2 receptors in the circling behaviour induced by apomorphine, SK & F 38393, pergolide and LY 171555 in 6-hydroxydopamine-lesioned rats

  2004cites this paper
• Brain dopamine receptors--research perspectives and potential sites of regulation.

  2004cites this paper
• Postsynaptic bimodal effect of sulpiride on locomotor activity induced by pergolide in catecholamine-depleted mice

  2004cites this paper
• Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393

  2004cites this paper
• Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor.

  2003cites this paper
• Ataxia and paroxysmal dyskinesia in mice lacking axonally transported FGF14.

  2002cites this paper
• Enone prodrugs of catecholamines

  2002cites this paper
• Tacrolimus, a specific inhibitor of calcineurin, modifies the locomotor activity of quinpirole, but not that of SKF82958, in male rats.

  2002cites this paper
• Parkinson's disease: medical and surgical treatment.

  2001cites this paper
• Differential effects of D1 and D2 agonists in MPTP‐treated primates: Functional implications for Parkinson's disease

  2001cites this paper
• Axis II psychopathology in individuals with traumatic brain injury

  2000cites this paper
• Dopamine D1 Receptors Synergize with D2, But Not D3 or D4, Receptors in the Striatum without the Involvement of Action Potentials

  2000cites this paper
• Rationale for Use of Dopamine Agonists in Parkinson's Disease: Review of Ergot Derivatives

  1999cites this paper
• D1/D2 receptor synergism on CREB DNA-binding activities in the caudate-putamen of rat.

  1999cites this paper
• Yawning and stretching induced by transcranial application of AC pulsed electromagnetic fields in Parkinson's disease.

  1999cites this paper
• Multisecond oscillations in firing rate in the globus pallidus: synergistic modulation by D1 and D2 dopamine receptors.

  1999cites this paper
• Antagonism of peripheral 5-HT4 receptors reduces visceral and cutaneous pain in mice, and induces visceral analgesia after simultaneous inactivation of 5-HT3 receptors.

  1998cites this paper
• Dopamine receptors: from structure to function.

  1998cites this paper
• [Central dopaminergic D1 agonists and treatment of Parkinson disease].

  1997cites this paper
• Behavioral effects of clozapine and dopamine receptor subtypes.

  1997cites this paper
• Dopaminergic and cholinergic interaction in cataleptic responses in mice.

  1997cites this paper
• D1/D2 Dopamine Receptor Interactions in Basal Ganglia Functions

  1997cites this paper
• Neurobiology of L-DOPAergic systems.

  1996cites this paper
• Synergistic effect of D1 and D2 dopamine receptors on AP-1 DNA-binding activity in the striatum and globus pallidus of the rat with a unilateral 6-OHDA lesion of the medical forebrain bundle.

  1996cites this paper
• Comparative Review of Dopamine Receptor Agonists in Parkinson’s Disease

  1996cites this paper
• Partial agonistic effects of OPC-14597, a potential antipsychotic agent, on yawning behavior in rats.

  1996cites this paper
• Neurotransmitter-like actions of L-DOPA.

  1995cites this paper
• Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?

  1995cites this paper
• Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test

  1995cites this paper
• Involvement of D1 and D2 dopamine systems in the behavioral effects of cocaine in rats.

  1995cites this paper
• Time course of bromocriptine induced excitation in the rat: behavioural and biochemical studies

  1995cites this paper
• New Insights into the Biology of Schizophrenia through the Mechanism of Action of Clozapine

  1995cites this paper
• Evidence for a dopamine receptor subtype sensitive to combination of D1 with D2 antagonist in measurement of G-protein activity using rat striatal membranes.

  1994cites this paper
• Acetylcholine, Dopamine and NMDA Transmission in the Caudate-Putamen: Their Interaction and Function as a Striatal Modulatory System

  1994cites this paper
• Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.

  1994cites this paper
• Role of the Nucleus Accumbens and the Striatum in the Production of Turning Behaviour in Intact Rats

  1994cites this paper
• The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐lesioned parkinsonian rhesus monkeys

  1994cites this paper
• Dopamine receptors: molecular biology, biochemistry and behavioural aspects.

  1994cites this paper
• Regulation of aromatic l‐amino acid decarboxylase in rat striatal synaptosomes: effects of dopamine receptor agonists and antagonists

  1994cites this paper
• The role of D1 and D2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: an animal analogue of schizophrenia.

  1993cites this paper
• D1 and D2 receptors and circling behavior in rats with unilateral lesion of the entopeduncular nucleus.

  1993cites this paper
• On-off effects of dopamine receptor agonists in the hemi-parkinsonian rat.

  1993cites this paper
• Effects of ibotenic acid lesion of the medial prefrontal cortex on dopamine agonist-related behaviors in the rat.

  1993cites this paper
• Regulation of striatal aromatic L-amino acid decarboxylase: effects of blockade or activation of dopamine receptors.

  1993cites this paper
• Vestibular compensation is affected by treatment with dopamine active agents.

  1993cites this paper
• D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease

  1992cites this paper
• Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.

  1992cites this paper
• Potentiation of licking in rats by stimulation of both D-1 and D-2 dopamine receptors

  1992cites this paper
• Advances in neuropharmacological rehabilitation for brain dysfunction.

  1992cites this paper
• Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.

  1992cites this paper
• Effect of LY 171555 and CY 208‐243 on tremor suppression in the MPTP monkey model of parkinsonism

  1992cites this paper
• Magnetic fields in the therapy of parkinsonism.

  1992cites this paper
• Influence of some dopaminergic agents on antinociception produced by quinine in mice

  1992cites this paper
• Sensitization, response fluctuation and long-term effect of SKF-82958 and bromocriptine in the hemi-parkinsonian rat.

  1992cites this paper
• Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide)

  1992cites this paper
• Effects of locally applied D1 and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions.

  1991cites this paper
• Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of Parkinsonism: role of priming.

  1991cites this paper
• Parkinson's Disease Monotherapy With Controlled‐Release MK‐458 (PHNO): Double‐Blind Study and Comparison to Carbidopa/Levodopa

  1991cites this paper
• Dopamine receptor classification, neuroanatomical distribution and in vivo imaging.

  1991cites this paper
• A computational model of levodopa pharmacodynamics in Parkinson's disease.

  1991cites this paper
• Effect of Gi protein ADP-ribosylation induced by pertussis toxin on dopamine-mediated behaviors.

  1991cites this paper
• Pergolide: a dopamine agonist at both D1 and D2 receptors.

  1991cites this paper
• Animal Models in Tardive Dyskinesia

  1991cites this paper
• Priming of the Behavioral Expression of Dopamine-Receptor Supersensitivity in the Basal Ganglia: Pharmacological and Biochemical Studies

  1991cites this paper
• Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue.

  1991cites this paper
• D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra.

  1991cites this paper
• Apparent enhancement by SCH 23390 of apomorphine-induced locomotor activity in mice.

  1991cites this paper